Send us Feedback

Mesa Laboratories (MLAB)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

MLAB » Topics » Stock Repurchase:

These excerpts taken from the MLAB 10-K filed Jun 29, 2009.
Stock Repurchase:

 

In November, 2005, the Company’s Board of Directors approved a program to repurchase up to 300,000 shares of its outstanding common stock.  Under the program, shares may be purchased from time to time in the open market at prevailing prices or in negotiated transactions off the market.  Shares purchased will be cancelled and repurchases of shares will be funded through existing cash reserves.

 

35


 

MESA LABORATORIES, INC.

NOTES TO FINANCIAL STATEMENTS

(CONTINUED)

 

7.                                      

Stock Repurchase:

 

In November, 2005, the Company’s Board of Directors approved a program to repurchase up to 300,000 shares of its outstanding common stock.  Under the program, shares may be purchased from time to time in the open market at prevailing prices or in negotiated transactions off the market.  Shares purchased will be cancelled and repurchases of shares will be funded through existing cash reserves.

 

35


 

MESA LABORATORIES, INC.

NOTES TO FINANCIAL STATEMENTS

(CONTINUED)

 

7.                                      

Stock Repurchase:

 

In November, 2005, the Company’s Board of Directors approved a program to repurchase up to 300,000 shares of its outstanding common stock.  Under the program, shares may be purchased from time to time in the open market at prevailing prices or in negotiated transactions off the market.  Shares purchased will be cancelled and repurchases of shares will be funded through existing cash reserves.

 

35


 

MESA LABORATORIES, INC.

NOTES TO FINANCIAL STATEMENTS

(CONTINUED)

 

7.                                      

Stock Repurchase:



 



In November, 2005, the Company’s Board of Directors approved a program
to repurchase up to 300,000 shares of its outstanding common stock.  Under the program, shares may be purchased
from time to time in the open market at prevailing prices or in negotiated
transactions off the market.  Shares
purchased will be cancelled and repurchases of shares will be funded through
existing cash reserves.



 



35















 



MESA LABORATORIES, INC.



NOTES TO
FINANCIAL STATEMENTS



(CONTINUED)



 



7.                                      

Stock Repurchase:



 



In November, 2005, the Company’s Board of Directors approved a program
to repurchase up to 300,000 shares of its outstanding common stock.  Under the program, shares may be purchased
from time to time in the open market at prevailing prices or in negotiated
transactions off the market.  Shares
purchased will be cancelled and repurchases of shares will be funded through
existing cash reserves.



 



35















 



MESA LABORATORIES, INC.



NOTES TO
FINANCIAL STATEMENTS



(CONTINUED)



 



7.                                      

Stock Repurchase:



 



In November, 2005, the Company’s Board of Directors approved a program
to repurchase up to 300,000 shares of its outstanding common stock.  Under the program, shares may be purchased
from time to time in the open market at prevailing prices or in negotiated
transactions off the market.  Shares
purchased will be cancelled and repurchases of shares will be funded through
existing cash reserves.



 



35















 



MESA LABORATORIES, INC.



NOTES TO
FINANCIAL STATEMENTS



(CONTINUED)



 



7.                                      

Stock Repurchase:



 



In November, 2005, the Company’s Board of Directors approved a program
to repurchase up to 300,000 shares of its outstanding common stock.  Under the program, shares may be purchased
from time to time in the open market at prevailing prices or in negotiated
transactions off the market.  Shares
purchased will be cancelled and repurchases of shares will be funded through
existing cash reserves.



 



35















 



MESA LABORATORIES, INC.



NOTES TO
FINANCIAL STATEMENTS



(CONTINUED)



 



7.                                      

EXCERPTS ON THIS PAGE:

10-K (7 sections)
Jun 29, 2009

RELATED TOPICS for MLAB:

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki